Perceptive Advisors’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Perceptive Advisors’s Portfolio ONSIW Stock Details ONSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-420,875	Closed	-$6K	–	142
2018 Q3	$6K	Buy	+420,875	New	+$10.4K	﹤0.01%	116
2017 Q3	–	Sell	-462,500	Closed	-$80K	–	170
2017 Q2	$80K	Hold	462,500	–	–	﹤0.01%	124
2017 Q1	$370K	Sell	462,500 -193,882	-30%	-$82.2K	0.02%	126
2016 Q4	$124K	Hold	656,382	–	–	0.01%	149
2016 Q3	$313K	Buy	656,382 +193,882	+42%	+$88.2K	0.02%	150
2016 Q2	$212K	Buy	+462,500	New	+$177K	0.01%	144

Perceptive Advisors's ONSIW Position: Q4 2018 in Review

Perceptive Advisors sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2018, closing a stake of 420,875 shares — an estimated $6K sold.

Perceptive Advisors first reported a position in ONSIW in Q2 2016 and held it in 6 quarters. The position peaked at $370K in Q1 2017. 0 funds tracked by Wall St. Rank hold ONSIW as of Q4 2018.

Perceptive Advisors reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2018 after selling out during the quarter.
Perceptive Advisors sold 420,875 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2018, an estimated $6K.
Perceptive Advisors first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 6 quarters.
Perceptive Advisors's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $370K in Q1 2017.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2018.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.